Atlas Trials

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

Clinical trial NCT01139138 · COMPLETED

Trial details

NCT number
NCT01139138
Sponsor
The Queen Elizabeth Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colorectal CancerColorectal CarcinomaColorectal TumorsNeoplasms, Colorectal
Start date
2010-06-01
Primary completion
2015-08-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.